Selected research
Industry Research
Biologics Development Service Industry Research Report 2026
Market perspective
The global Biologics Development Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biologics Development Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biologics Development Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biologics Development Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biologics Development Service include Meso Scale Discovery, Patheon, Immunologix, GenScript, Promega, Recibiopharm, Alcami Biologics, Leadgene Biomedical and Samsung Biologics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biologics Development Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biologics Development Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biologics Development Service Market by Company
Meso Scale Discovery
Patheon
Immunologix
GenScript
Promega
Recibiopharm
Alcami Biologics
Leadgene Biomedical
Samsung Biologics
Lonza
ImmunoGen
Seattle Genetics
Roche
Takeda
Biologics Development Service Segment by Type
Vaccine
Blood and Blood Components
Tissue and Recombinant Therapeutic Proteins
Others
Biologics Development Service Segment by Application
Tumor Treatment
Chronic Disease Treatment
Enzyme and Hormone Deficiencies
Others
Biologics Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologics Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biologics Development Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccine
- Blood and Blood Components
- Tissue and Recombinant Therapeutic Proteins
- Others
Applications
- Tumor Treatment
- Chronic Disease Treatment
- Enzyme and Hormone Deficiencies
- Others
Companies covered
- Meso Scale Discovery
- Patheon
- Immunologix
- GenScript
- Promega
- Recibiopharm
- Alcami Biologics
- Leadgene Biomedical
- Samsung Biologics
- Lonza
- ImmunoGen
- Seattle Genetics
- Roche
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biologics Development Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Vaccine
- 2.2.3 Blood and Blood Components
- 2.2.4 Tissue and Recombinant Therapeutic Proteins
- 2.2.5 Others
- 2.3 Biologics Development Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Tumor Treatment
- 2.3.3 Chronic Disease Treatment
- 2.3.4 Enzyme and Hormone Deficiencies
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Biologics Development Service Breakdown Data by Type
- 3.1 Global Biologics Development Service Historic Market Size by Type (2021-2026)
- 3.2 Global Biologics Development Service Forecasted Market Size by Type (2027-2032)
4 Biologics Development Service Breakdown Data by Application
- 4.1 Global Biologics Development Service Historic Market Size by Application (2021-2026)
- 4.2 Global Biologics Development Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biologics Development Service Market Perspective (2021-2032)
- 5.2 Global Biologics Development Service Growth Trends by Region
- 5.2.1 Global Biologics Development Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biologics Development Service Historic Market Size by Region (2021-2026)
- 5.2.3 Biologics Development Service Forecasted Market Size by Region (2027-2032)
- 5.3 Biologics Development Service Market Dynamics
- 5.3.1 Biologics Development Service Industry Trends
- 5.3.2 Biologics Development Service Market Drivers
- 5.3.3 Biologics Development Service Market Challenges
- 5.3.4 Biologics Development Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biologics Development Service Players by Revenue
- 6.1.1 Global Top Biologics Development Service Players by Revenue (2021-2026)
- 6.1.2 Global Biologics Development Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Biologics Development Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biologics Development Service Head Office and Area Served
- 6.4 Global Biologics Development Service Players, Product Type & Application
- 6.5 Global Biologics Development Service Manufacturers Established Date
- 6.6 Global Biologics Development Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biologics Development Service Market Size (2021-2032)
- 7.2 North America Biologics Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biologics Development Service Market Size by Country (2021-2026)
- 7.4 North America Biologics Development Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biologics Development Service Market Size (2021-2032)
- 8.2 Europe Biologics Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biologics Development Service Market Size by Country (2021-2026)
- 8.4 Europe Biologics Development Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biologics Development Service Market Size (2021-2032)
- 9.2 Asia-Pacific Biologics Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biologics Development Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biologics Development Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biologics Development Service Market Size (2021-2032)
- 10.2 South America Biologics Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biologics Development Service Market Size by Country (2021-2026)
- 10.4 South America Biologics Development Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biologics Development Service Market Size (2021-2032)
- 11.2 Middle East & Africa Biologics Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biologics Development Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biologics Development Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Meso Scale Discovery
- 12.1.1 Meso Scale Discovery Company Information
- 12.1.2 Meso Scale Discovery Business Overview
- 12.1.3 Meso Scale Discovery Revenue in Biologics Development Service Business (2021-2026)
- 12.1.4 Meso Scale Discovery Biologics Development Service Product Portfolio
- 12.1.5 Meso Scale Discovery Recent Developments
- 12.2 Patheon
- 12.2.1 Patheon Company Information
- 12.2.2 Patheon Business Overview
- 12.2.3 Patheon Revenue in Biologics Development Service Business (2021-2026)
- 12.2.4 Patheon Biologics Development Service Product Portfolio
- 12.2.5 Patheon Recent Developments
- 12.3 Immunologix
- 12.3.1 Immunologix Company Information
- 12.3.2 Immunologix Business Overview
- 12.3.3 Immunologix Revenue in Biologics Development Service Business (2021-2026)
- 12.3.4 Immunologix Biologics Development Service Product Portfolio
- 12.3.5 Immunologix Recent Developments
- 12.4 GenScript
- 12.4.1 GenScript Company Information
- 12.4.2 GenScript Business Overview
- 12.4.3 GenScript Revenue in Biologics Development Service Business (2021-2026)
- 12.4.4 GenScript Biologics Development Service Product Portfolio
- 12.4.5 GenScript Recent Developments
- 12.5 Promega
- 12.5.1 Promega Company Information
- 12.5.2 Promega Business Overview
- 12.5.3 Promega Revenue in Biologics Development Service Business (2021-2026)
- 12.5.4 Promega Biologics Development Service Product Portfolio
- 12.5.5 Promega Recent Developments
- 12.6 Recibiopharm
- 12.6.1 Recibiopharm Company Information
- 12.6.2 Recibiopharm Business Overview
- 12.6.3 Recibiopharm Revenue in Biologics Development Service Business (2021-2026)
- 12.6.4 Recibiopharm Biologics Development Service Product Portfolio
- 12.6.5 Recibiopharm Recent Developments
- 12.7 Alcami Biologics
- 12.7.1 Alcami Biologics Company Information
- 12.7.2 Alcami Biologics Business Overview
- 12.7.3 Alcami Biologics Revenue in Biologics Development Service Business (2021-2026)
- 12.7.4 Alcami Biologics Biologics Development Service Product Portfolio
- 12.7.5 Alcami Biologics Recent Developments
- 12.8 Leadgene Biomedical
- 12.8.1 Leadgene Biomedical Company Information
- 12.8.2 Leadgene Biomedical Business Overview
- 12.8.3 Leadgene Biomedical Revenue in Biologics Development Service Business (2021-2026)
- 12.8.4 Leadgene Biomedical Biologics Development Service Product Portfolio
- 12.8.5 Leadgene Biomedical Recent Developments
- 12.9 Samsung Biologics
- 12.9.1 Samsung Biologics Company Information
- 12.9.2 Samsung Biologics Business Overview
- 12.9.3 Samsung Biologics Revenue in Biologics Development Service Business (2021-2026)
- 12.9.4 Samsung Biologics Biologics Development Service Product Portfolio
- 12.9.5 Samsung Biologics Recent Developments
- 12.10 Lonza
- 12.10.1 Lonza Company Information
- 12.10.2 Lonza Business Overview
- 12.10.3 Lonza Revenue in Biologics Development Service Business (2021-2026)
- 12.10.4 Lonza Biologics Development Service Product Portfolio
- 12.10.5 Lonza Recent Developments
- 12.11 ImmunoGen
- 12.11.1 ImmunoGen Company Information
- 12.11.2 ImmunoGen Business Overview
- 12.11.3 ImmunoGen Revenue in Biologics Development Service Business (2021-2026)
- 12.11.4 ImmunoGen Biologics Development Service Product Portfolio
- 12.11.5 ImmunoGen Recent Developments
- 12.12 Seattle Genetics
- 12.12.1 Seattle Genetics Company Information
- 12.12.2 Seattle Genetics Business Overview
- 12.12.3 Seattle Genetics Revenue in Biologics Development Service Business (2021-2026)
- 12.12.4 Seattle Genetics Biologics Development Service Product Portfolio
- 12.12.5 Seattle Genetics Recent Developments
- 12.13 Roche
- 12.13.1 Roche Company Information
- 12.13.2 Roche Business Overview
- 12.13.3 Roche Revenue in Biologics Development Service Business (2021-2026)
- 12.13.4 Roche Biologics Development Service Product Portfolio
- 12.13.5 Roche Recent Developments
- 12.14 Takeda
- 12.14.1 Takeda Company Information
- 12.14.2 Takeda Business Overview
- 12.14.3 Takeda Revenue in Biologics Development Service Business (2021-2026)
- 12.14.4 Takeda Biologics Development Service Product Portfolio
- 12.14.5 Takeda Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst